Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block
- Conditions
- Ultrasound-guided Interscalene Nerve BlockShoulder Arthroscopy
- Interventions
- Procedure: Interscalene block for shoulder arthroscopy
- Registration Number
- NCT01877330
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
This is a prospective randomized clinical trial to determine where is the optimal location for local anesthetic injection for ultrasound guided interscalene nerve blocks. The investigators are investigating if local anesthetic deposited between the nerve roots is more effective than local anesthetic deposited in the interscalene groove.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 208
ASA I-II patients who are 18 years and older and who are scheduled for shoulder arthroscopy are eligible for enrollment provided they do not have any of the following exclusion criteria.
- chronic pain
- high preoperative opioid requirement
- age < 18 years old
- non-English speaking
- contraindication to regional anesthesia (allergy to local anesthetics, coagulopathy, severe thrombocytopenia, pre-existing neuropathy in operative limb, infection at puncture site)
- need for postoperative nerve function monitoring
- patient refusal
- dementia
- pulmonary disease or low baseline oxygen saturation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Injection between nerve roots Interscalene block for shoulder arthroscopy Patients undergoing shoulder arthroscopy will have an interscalene nerve block by injection of ropivacaine in the interscalene groove inbetween the C5 and C6 nerve roots. Injection in interscalene groove Interscalene block for shoulder arthroscopy Patients undergoing shoulder arthroscopy will have an interscalene nerve block by injection of ropivacaine in the interscalene groove anterior and posterior to the brachial plexus nerves.
- Primary Outcome Measures
Name Time Method Onset of motor blockade 1 hour from time of injection Time to loss of shoulder abduction.
- Secondary Outcome Measures
Name Time Method Number of needle passes 1 hour Patient Satisfaction Score 24 hours Opioid consumption 24 hours Opioid consumption - perioperative and post discharge
Duration of nerve block 24 hours Duration of analgesia from nerve block
Quality of Nerve block 24 hours onset of sensory block
Incidence of post-operative nausea/vomiting 24 hours Number of paresthesias 1 hour number of paresthesia experience during nerve block
Residual paresthesia 24 hour incidence of residual paresthesias
Trial Locations
- Locations (1)
UCSF Orthopedic Institute
🇺🇸San Francisco, California, United States